Literature DB >> 11817365

Schizonepeta tenuifolia: chemistry, pharmacology, and clinical applications.

Dennis Fung1, Clara B S Lau.   

Abstract

This article presents an up-to-date review of the plant Schizonepeta tenuifolia (Jingjie), of family Labiatae, with respect to its traditional uses, chemical constituents, various pharmacological activities, and clinical effects. Nonetheless, its mechanism of actions, adverse effects, drug interactions, and contraindications remain unclear. With the global growth on the use of herbal products, Jingjie has been commonly marketed for the treatment of common cold and fever in Chinese proprietary medicines. Hence, further studies will be warranted to show its efficacy and safety.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11817365     DOI: 10.1177/0091270002042001003

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  10 in total

1.  Antiviral activity of Schizonepeta tenuifolia Briquet against noroviruses via induction of antiviral interferons.

Authors:  Yee Ching Ng; Ye Won Kim; Jeong-Su Lee; Sung Joon Lee; Moon Jung Song
Journal:  J Microbiol       Date:  2018-08-23       Impact factor: 3.422

2.  Quantitative comparative analysis of the bio-active and toxic constituents of leaves and spikes of Schizonepeta tenuifolia at different harvesting times.

Authors:  Sheng Yu; Yiwen Chen; Li Zhang; Mingqiu Shan; Yuping Tang; Anwei Ding
Journal:  Int J Mol Sci       Date:  2011-10-10       Impact factor: 5.923

3.  Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis.

Authors:  George B Lenon; Charlie C L Xue; David F Story; Frank C K Thien; Sarah McPhee; Chun G Li
Journal:  Chin Med       Date:  2007-02-15       Impact factor: 5.455

4.  P-coumaric acid regulates exon 12 splicing of the ATP7B gene by modulating hnRNP A1 protein expressions.

Authors:  Ying-Ju Lin; Tsung-Jung Ho; Ting-Hsu Lin; Wei-Yi Hsu; Shao-Mei Huang; Chiu-Chu Liao; Chih-Ho Lai; Xiang Liu; Hsinyi Tsang; Chien-Chen Lai; Fuu-Jen Tsai
Journal:  Biomedicine (Taipei)       Date:  2015-06-06

5.  Antiviral activities of Schizonepeta tenuifolia Briq. against enterovirus 71 in vitro and in vivo.

Authors:  Sin-Guang Chen; Mei-Ling Cheng; Kuan-Hsing Chen; Jim-Tong Horng; Ching-Chuan Liu; Shih-Min Wang; Hiroaki Sakurai; Yann-Lii Leu; Shulhn-Der Wang; Hung-Yao Ho
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

6.  Color discrimination and gas chromatography-mass spectrometry fingerprint based on chemometrics analysis for the quality evaluation of Schizonepetae Spica.

Authors:  Xindan Liu; Ying Zhang; Menghua Wu; Zhiguo Ma; Hui Cao
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

7.  Botanical formulation, TADIOS, alleviates lipopolysaccharide (LPS)-Induced acute lung injury in mice via modulation of the Nrf2-HO-1 signaling pathway.

Authors:  Wonwoo Lee; Chang Hyung Lee; Jungkyu Lee; Yoonseon Jeong; Jong-Hyung Park; In-Jeong Nam; Doo Suk Lee; Hyun Myung Lee; Jaehyun Lee; Nayoung Yun; Jisun Song; Sooyeon Choi; Sunyoung Kim
Journal:  J Ethnopharmacol       Date:  2021-01-07       Impact factor: 4.360

8.  Rapid Simultaneous Determination of 43 Pesticide Residues in Schizonepeta tenuifolia by Gas Chromatography Mass Spectrometry.

Authors:  Guo-Wei Zhou; Yong-Mei Li; Chun-Ni Liu; Hong-Min Ren; Hai-Ying Li
Journal:  Int J Anal Chem       Date:  2021-12-13       Impact factor: 1.885

9.  Effects of Salt Stress on Plant Growth, Antioxidant Capacity, Glandular Trichome Density, and Volatile Exudates of Schizonepeta tenuifolia Briq.

Authors:  Ying Zhou; Nanyu Tang; Lijin Huang; Yongjuan Zhao; Xiaoqing Tang; Kangcai Wang
Journal:  Int J Mol Sci       Date:  2018-01-15       Impact factor: 5.923

10.  Inhibition of Human Kallikrein 5 Protease by Triterpenoids from Natural Sources.

Authors:  Yosuke Matsubara; Takashi Matsumoto; Junichi Koseki; Atsushi Kaneko; Setsuya Aiba; Kenshi Yamasaki
Journal:  Molecules       Date:  2017-10-27       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.